BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 20364085)

  • 1. Proteasomal degradation of retinoid X receptor alpha reprograms transcriptional activity of PPARgamma in obese mice and humans.
    Lefebvre B; Benomar Y; Guédin A; Langlois A; Hennuyer N; Dumont J; Bouchaert E; Dacquet C; Pénicaud L; Casteilla L; Pattou F; Ktorza A; Staels B; Lefebvre P
    J Clin Invest; 2010 May; 120(5):1454-68. PubMed ID: 20364085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flightless-1, a novel transcriptional modulator of PPARγ through competing with RXRα.
    Choi JS; Choi SS; Kim ES; Seo YK; Seo JK; Kim EK; Suh PG; Choi JH
    Cell Signal; 2015 Mar; 27(3):614-20. PubMed ID: 25479590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GQ-16, a TZD-Derived Partial PPARγ Agonist, Induces the Expression of Thermogenesis-Related Genes in Brown Fat and Visceral White Fat and Decreases Visceral Adiposity in Obese and Hyperglycemic Mice.
    Coelho MS; de Lima CL; Royer C; Silva JB; Oliveira FC; Christ CG; Pereira SA; Bao SN; Lima MC; Pitta MG; Pitta IR; Neves FA; Amato AA
    PLoS One; 2016; 11(5):e0154310. PubMed ID: 27138164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adipocyte-specific expression of murine resistin is mediated by synergism between peroxisome proliferator-activated receptor gamma and CCAAT/enhancer-binding proteins.
    Tomaru T; Steger DJ; Lefterova MI; Schupp M; Lazar MA
    J Biol Chem; 2009 Mar; 284(10):6116-25. PubMed ID: 19126543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptor (PPAR)alpha activation increases adiponectin receptors and reduces obesity-related inflammation in adipose tissue: comparison of activation of PPARalpha, PPARgamma, and their combination.
    Tsuchida A; Yamauchi T; Takekawa S; Hada Y; Ito Y; Maki T; Kadowaki T
    Diabetes; 2005 Dec; 54(12):3358-70. PubMed ID: 16306350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterodimer formation with retinoic acid receptor RXRα modulates coactivator recruitment by peroxisome proliferator-activated receptor PPARγ.
    Kilu W; Merk D; Steinhilber D; Proschak E; Heering J
    J Biol Chem; 2021 Jul; 297(1):100814. PubMed ID: 34081964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligand-Dependent Corepressor (LCoR) Is a Rexinoid-Inhibited Peroxisome Proliferator-Activated Receptor γ-Retinoid X Receptor α Coactivator.
    Shalom-Barak T; Liersemann J; Memari B; Flechner L; Devor CE; Bernardo TM; Kim S; Matsumoto N; Friedman SL; Evans RM; White JH; Barak Y
    Mol Cell Biol; 2018 May; 38(9):. PubMed ID: 29463649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel selective peroxisome proliferator-activator receptor-gamma modulator-SPPARgammaM5 improves insulin sensitivity with diminished adverse cardiovascular effects.
    Chang CH; McNamara LA; Wu MS; Muise ES; Tan Y; Wood HB; Meinke PT; Thompson JR; Doebber TW; Berger JP; McCann ME
    Eur J Pharmacol; 2008 Apr; 584(1):192-201. PubMed ID: 18346728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C/EBPalpha and the corepressors CtBP1 and CtBP2 regulate repression of select visceral white adipose genes during induction of the brown phenotype in white adipocytes by peroxisome proliferator-activated receptor gamma agonists.
    Vernochet C; Peres SB; Davis KE; McDonald ME; Qiang L; Wang H; Scherer PE; Farmer SR
    Mol Cell Biol; 2009 Sep; 29(17):4714-28. PubMed ID: 19564408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptor gamma agonist rosiglitazone increases expression of very low density lipoprotein receptor gene in adipocytes.
    Takazawa T; Yamauchi T; Tsuchida A; Takata M; Hada Y; Iwabu M; Okada-Iwabu M; Ueki K; Kadowaki T
    J Biol Chem; 2009 Oct; 284(44):30049-57. PubMed ID: 19706614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obese mice lacking inducible nitric oxide synthase are sensitized to the metabolic actions of peroxisome proliferator-activated receptor-gamma agonism.
    Dallaire P; Bellmann K; Laplante M; Gélinas S; Centeno-Baez C; Penfornis P; Peyot ML; Latour MG; Lamontagne J; Trujillo ME; Scherer PE; Prentki M; Deshaies Y; Marette A
    Diabetes; 2008 Aug; 57(8):1999-2011. PubMed ID: 18458147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rosiglitazone induction of Insig-1 in white adipose tissue reveals a novel interplay of peroxisome proliferator-activated receptor gamma and sterol regulatory element-binding protein in the regulation of adipogenesis.
    Kast-Woelbern HR; Dana SL; Cesario RM; Sun L; de Grandpre LY; Brooks ME; Osburn DL; Reifel-Miller A; Klausing K; Leibowitz MD
    J Biol Chem; 2004 Jun; 279(23):23908-15. PubMed ID: 15073165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin resistance and metabolic derangements in obese mice are ameliorated by a novel peroxisome proliferator-activated receptor γ-sparing thiazolidinedione.
    Chen Z; Vigueira PA; Chambers KT; Hall AM; Mitra MS; Qi N; McDonald WG; Colca JR; Kletzien RF; Finck BN
    J Biol Chem; 2012 Jul; 287(28):23537-48. PubMed ID: 22621923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of diosgenin on metabolic dysfunction: Role of ERβ in the regulation of PPARγ.
    Wang X; Liu J; Long Z; Sun Q; Liu Y; Wang L; Zhang X; Hai C
    Toxicol Appl Pharmacol; 2015 Dec; 289(2):286-96. PubMed ID: 26408789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De-novo identification of PPARgamma/RXR binding sites and direct targets during adipogenesis.
    Hamza MS; Pott S; Vega VB; Thomsen JS; Kandhadayar GS; Ng PW; Chiu KP; Pettersson S; Wei CL; Ruan Y; Liu ET
    PLoS One; 2009; 4(3):e4907. PubMed ID: 19300518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional role of RXRs and PPARgamma in mature adipocytes.
    Metzger D; Imai T; Jiang M; Takukawa R; Desvergne B; Wahli W; Chambon P
    Prostaglandins Leukot Essent Fatty Acids; 2005 Jul; 73(1):51-8. PubMed ID: 15936932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The nuclear receptor corepressors NCoR and SMRT decrease peroxisome proliferator-activated receptor gamma transcriptional activity and repress 3T3-L1 adipogenesis.
    Yu C; Markan K; Temple KA; Deplewski D; Brady MJ; Cohen RN
    J Biol Chem; 2005 Apr; 280(14):13600-5. PubMed ID: 15691842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PPARgamma agonism increases rat adipose tissue lipolysis, expression of glyceride lipases, and the response of lipolysis to hormonal control.
    Festuccia WT; Laplante M; Berthiaume M; Gélinas Y; Deshaies Y
    Diabetologia; 2006 Oct; 49(10):2427-36. PubMed ID: 16906479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WISP1/CCN4 inhibits adipocyte differentiation through repression of PPARγ activity.
    Ferrand N; Béreziat V; Moldes M; Zaoui M; Larsen AK; Sabbah M
    Sci Rep; 2017 May; 7(1):1749. PubMed ID: 28496206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasticizers used in food-contact materials affect adipogenesis in 3T3-L1 cells.
    Pomatto V; Cottone E; Cocci P; Mozzicafreddo M; Mosconi G; Nelson ER; Palermo FA; Bovolin P
    J Steroid Biochem Mol Biol; 2018 Apr; 178():322-332. PubMed ID: 29410257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.